CN Patent
CN115175913B — 取代的双三环化合物及其药物组合物和用途
Assigned to Zhihe Shandong Pharmaceutical Factory Co ltd · Expires 2023-11-28 · 2y expired
What this patent protects
一种取代的双三环化合物及其药物组合和用途,所述取代的双三环化合物如式(I)所示;该化合物对病毒具有抑制作用,可用于抗流感病毒。
USPTO Abstract
一种取代的双三环化合物及其药物组合和用途,所述取代的双三环化合物如式(I)所示;该化合物对病毒具有抑制作用,可用于抗流感病毒。
Drugs covered by this patent
- Xofluza (BALOXAVIR MARBOXIL) · Roche
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.